Evaluation of N Nitrosamines – Examining the Tools and Systems to Assist in such Assessments
Date: 25 November 2020
Time: 14.00 (GMT); 15.00 (CET); 9.00 (ET)
Tutors: Dr Andrew Teasdale
This 90 minute free to attend webinar will look to example the very latest in terms of N Nitrosamines. It will examine new and evolving regulations as well as looking at specific risk factors and the scientific investigations currently being undertaken to both better understand and contextualise the range of potential risk factors; trying where possible to tease out what is risk and what is not. In parallel it simultaneously look at the latest advances in technology to support both research and risk assessment.
Who should view the recording? Chemists / Analysts, Quality Assurance professionals, Regulatory Affairs, Directors / VPs with overall accountability
This webinar will be presented by Dr Andrew Teasdale, AstraZeneca. Andrew is the author of over 50 pier reviewed scientific papers as well as two books:
- ICH Quality Guidelines: An Implementation Guide,
- Genotoxic Impurities: Strategies for Identification and Control (published originally in 2010, a much revised second edition is planned for release in early 2021.
- Andrew is also tutor on the 2-day course: Practical management of impurities and development of effective and comprehensive control strategies.
We’d like to thank Anatune, Arcinova, LGC, Lhasa and Waters for their kind sponsorship of this presentation.
The webinar will last for approximately 90 minutes and starts at the following time:
2.00 pm UK
3.00 pm Central Europe
9.00 am East Coast US
If you are unable to attend on the day, don’t worry – we will send you a link to the recording and slides afterwards.